Cibc World Markets Corp Acquires New Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)
Cibc World Markets Corp bought a new position in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) during the 4th quarter, HoldingsChannel.com reports. The fund bought 10,463 shares of the biopharmaceutical company’s stock, valued at approximately $218,000. A number of other hedge funds have also bought and sold shares of the stock. Steward Partners […]
